JP2000512007A - ヘモグロビンを含有する医療サンプルの分析方法 - Google Patents
ヘモグロビンを含有する医療サンプルの分析方法Info
- Publication number
- JP2000512007A JP2000512007A JP09541628A JP54162897A JP2000512007A JP 2000512007 A JP2000512007 A JP 2000512007A JP 09541628 A JP09541628 A JP 09541628A JP 54162897 A JP54162897 A JP 54162897A JP 2000512007 A JP2000512007 A JP 2000512007A
- Authority
- JP
- Japan
- Prior art keywords
- sample
- value
- hemoglobin
- measured
- measurement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 光学測定による、遊離ヘモグロビンを含有するサンプル中の被検体の測 定方法であって、 (a) 分析するサンプルの空値を測定する段階と、 (b) ヘモグロビン非含有基準サンプルの空値を測定する段階と、 (c) 被検体濃度の未補正値を測定する段階と、 (d) 段階(c)において得られた値を、段階(a)および(b)で得られた値 と相関させることにより補正して、該被検体濃度の補正値を得る段階と により該被検体濃度の測定値を補正する、前記方法。 2. 前記被検体濃度の補正値が、以下の関係式: C’サンフ゜ル=Cサンフ゜ル−F・E1サンフ゜ル+F・E1基準 (式中、C’サンフ゜ルは該被検体濃度の補正値であり、 Cサンフ゜ルはサンプル中の該被検体濃度の未補正測定値であり、 Fはテストに特有の補正係数であり、 E1サンフ゜ルは前記サンプル中で測定された空値であり、および、 E1基準は前記基準サンプル中で測定された値である) により算出される、請求項1に記載の方法。 3. 前記被検体の測定を、600〜700nmの範囲での光学測定により行う、請求 項1または2に記載の方法。 4. 血液代用品を含有するサンプルが測定される、請求項1〜3のいずれか 1項に記載の方法。 5. 前記サンプルの総タンパク質含量が測定される、請求項1〜4のいずれ か1項に記載の方法。 6. 前記総タンパク質含量の測定がビウレット法により行われる、請求項5 に記載の方法。 7. 前記サンプル中の鉄含量が測定される、請求項1〜4のいずれか1項に 記載の方法。 8. 前記鉄含量がフェロジン法により測定される、請求項7に記載の方法。 9. 前記サンプル中のアルブミン含量が測定される、請求項1〜4のいずれ か1項に記載の方法。 10. 前記アルブミン含量が、ブロモクレゾールグリーン法もしくはブロモクレ ゾールパープル法により測定される、請求項9に記載の方法。 11. 高脂血症性サンプルの測定において、清浄剤を加える、請求項1〜10の いずれか1項に記載の方法。 12. 前記測定が、血清もしくは血漿サンプルにおいて行われる、請求項1〜 11のいずれか1項に記載の方法。 13. 臨床的に健康な被験者の血清もしくは血漿サンプルを基準サンプルとし て使用する、請求項1〜12のいずれか1項に記載の方法。 14. 自動分析装置にて実施される、請求項1〜13のいずれか1項に記載の方 法。 15. 前記自動分析装置が、前記被検体濃度の補正値がすでに印字されるよう にプログラムされている、請求項14に記載の方法。 16. 前記テストに特有の補正係数Fの決定が、 (a)少なくとも1つのサンプルがヘモグロビンを含有せず、少なくとも2 つのサンプルが異なる濃度の遊離ヘモグロビンを含有する、同量の被検体 を含有する少なくとも3つのサンプルからなる組を調製する段階と、 (b) 各サンプルの空値を測定して、ヘモグロビン非含有サンプルと比較 した場合のヘモグロビンの存在により生じるサンプル空値の増加を決定す る段階と、 (c) 各サンプル中の前記未補正被検体濃度を測定して、ヘモグロビン非 含有基準サンプルと比較した場合のヘモグロビンの存在により生じる測定 値の誤差を決定する段階と、 (d) 段階(c)において決定された該測定値の誤差を、段階(b)において 決定された該サンプル空値の増加と相関させて、該テストに特有の補正係 数を得る段階と を含む、請求項2に記載の方法。 17. 少なくとも5個のサンプルが異なる濃度の遊離ヘモグロビンを含有する 、 サンプルからなる組を調製する、請求項16に記載の方法。 18. 0mg/dl〜少なくとも1000mg/dlにわたる遊離ヘモグロビン濃度を有する サンプルからなる組を調製する、請求項16または17に記載の方法。 19. 遊離ヘモグロビンを含有するサンプルについて、サンプルに特有の補正 係数F’を以下の関係式: F’=ΔC:ΔE1 (式中、 ΔCは、個々のサンプルについて、基準サンプルと比較した場合の遊離ヘ モグロビンの存在によって生じる測定値の誤差量であり、および、 ΔE1は、個々のサンプルについて、基準サンプルと比較した場合の遊離 ヘモグロビンの存在によって生じるサンプル空値の増加である。) により決定し、個々のサンプルそれぞれについて決定された該補正係数 F’の平均を算出することにより、テストに特有の補正係数Fを決定する 、請求項16〜18のいずれか1項に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19622089.0 | 1996-05-31 | ||
DE19622089A DE19622089A1 (de) | 1996-05-31 | 1996-05-31 | Verfahren zur Analyse Hämoglobin enthaltender medizinischer Proben |
PCT/EP1997/002834 WO1997045732A1 (de) | 1996-05-31 | 1997-05-30 | Verfahren zur analyse hämoglobin enthaltender medizinischer proben |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2000512007A true JP2000512007A (ja) | 2000-09-12 |
JP2000512007A5 JP2000512007A5 (ja) | 2004-12-09 |
JP3814300B2 JP3814300B2 (ja) | 2006-08-23 |
Family
ID=7795916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54162897A Expired - Fee Related JP3814300B2 (ja) | 1996-05-31 | 1997-05-30 | ヘモグロビンを含有する医療サンプルの分析方法 |
Country Status (16)
Country | Link |
---|---|
US (1) | US6207459B1 (ja) |
EP (1) | EP0906569B1 (ja) |
JP (1) | JP3814300B2 (ja) |
KR (1) | KR20000016036A (ja) |
CN (1) | CN1220007A (ja) |
AT (1) | ATE208899T1 (ja) |
AU (1) | AU3031497A (ja) |
CA (1) | CA2255843C (ja) |
CZ (1) | CZ391098A3 (ja) |
DE (2) | DE19622089A1 (ja) |
ES (1) | ES2163775T3 (ja) |
IL (1) | IL126718A0 (ja) |
NZ (1) | NZ332444A (ja) |
PL (1) | PL330229A1 (ja) |
TW (1) | TW408223B (ja) |
WO (1) | WO1997045732A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7198955B1 (en) * | 1997-03-03 | 2007-04-03 | Nir Diagnostics Inc. | Method and apparatus for measurement of blood substitutes |
DE19846301A1 (de) * | 1998-10-08 | 2000-04-13 | Roche Diagnostics Gmbh | Verfahren zur Bestimmung von alkalischer Phospatase unter Beseitigung von Hämoglobin-Störungen |
DE19846300A1 (de) * | 1998-10-08 | 2000-04-13 | Roche Diagnostics Gmbh | Verfahren zur Bestimmung von alkalischer Phosphatase unter Reduzierung von Hämoglobin-Störungen durch das Rate-Blank-Verfahren |
KR100343753B1 (ko) * | 2000-02-17 | 2002-07-20 | 강건 | 빌리루빈의 농도와 헤모글로빈의 함유량 측정기 |
US20060205082A1 (en) * | 2005-03-10 | 2006-09-14 | Middleton John S | Reaction rate determination |
JP2009031202A (ja) * | 2007-07-30 | 2009-02-12 | Hitachi High-Technologies Corp | 自動分析装置 |
CN103376327A (zh) * | 2012-04-28 | 2013-10-30 | 通用电气公司 | 检测抗体或融合蛋白的浓度的方法 |
KR102310652B1 (ko) * | 2014-08-12 | 2021-10-12 | 삼성전자주식회사 | 샘플 검사 방법, 미세유동장치 및 검사장치 |
WO2016024791A1 (en) * | 2014-08-12 | 2016-02-18 | Samsung Electronics Co., Ltd. | Sample test method, microfluidic device, and test device |
WO2020159599A1 (en) * | 2019-01-29 | 2020-08-06 | Siemens Healthcare Diagnostics Inc. | TURBIDITY NORMALIZATION ALGORITHM AND METHODS OF REDUCING INTRALIPID/LIPEMIA INTERFERENCE IN HEMOGLOBIN A1c ASSAYS |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS604929B2 (ja) * | 1977-11-11 | 1985-02-07 | 株式会社日立製作所 | 比色分析方法 |
JPS6118693B2 (ja) * | 1977-10-31 | 1986-05-14 | Hitachi Ltd | |
JPS6350743A (ja) * | 1986-08-20 | 1988-03-03 | Hitachi Ltd | 溶血のある血液試料の分析方法 |
JPH05505243A (ja) * | 1990-10-11 | 1993-08-05 | シナームド、インコーポレーテッド | 血清鉄アッセイに関する試薬及び方法 |
JPH08101191A (ja) * | 1994-08-03 | 1996-04-16 | Boehringer Mannheim Gmbh | 溶血による干渉を回避する検体の分析方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3310382A (en) * | 1963-02-04 | 1967-03-21 | George R Kingsley | Biuret reagent |
US3533749A (en) * | 1967-09-12 | 1970-10-13 | Warner Lambert Pharmaceutical | Method for the determination of total albumin |
US3558278A (en) * | 1967-12-26 | 1971-01-26 | Baxter Laboratories Inc | Determination of albumin |
IT1100475B (it) * | 1978-11-08 | 1985-09-28 | R C O Ricerche Di Chimica Clin | Metodo e composizioni per la determinazione diretta del ferro mel stero ematico |
US5945272A (en) * | 1993-06-04 | 1999-08-31 | Biotime, Incorporated | Plasma expanders and blood substitutes |
DE4401754A1 (de) * | 1994-01-21 | 1995-07-27 | Boehringer Mannheim Gmbh | Verfahren und Reagenz zur Bestimmung von Eisen |
-
1996
- 1996-05-31 DE DE19622089A patent/DE19622089A1/de not_active Withdrawn
-
1997
- 1997-05-13 TW TW086106364A patent/TW408223B/zh active
- 1997-05-30 PL PL97330229A patent/PL330229A1/xx unknown
- 1997-05-30 JP JP54162897A patent/JP3814300B2/ja not_active Expired - Fee Related
- 1997-05-30 IL IL12671897A patent/IL126718A0/xx unknown
- 1997-05-30 NZ NZ332444A patent/NZ332444A/xx unknown
- 1997-05-30 ES ES97925031T patent/ES2163775T3/es not_active Expired - Lifetime
- 1997-05-30 AU AU30314/97A patent/AU3031497A/en not_active Abandoned
- 1997-05-30 CA CA002255843A patent/CA2255843C/en not_active Expired - Fee Related
- 1997-05-30 CZ CZ983910A patent/CZ391098A3/cs unknown
- 1997-05-30 EP EP97925031A patent/EP0906569B1/de not_active Expired - Lifetime
- 1997-05-30 WO PCT/EP1997/002834 patent/WO1997045732A1/de not_active Application Discontinuation
- 1997-05-30 DE DE59705397T patent/DE59705397D1/de not_active Expired - Lifetime
- 1997-05-30 US US09/147,288 patent/US6207459B1/en not_active Expired - Lifetime
- 1997-05-30 CN CN97194987A patent/CN1220007A/zh active Pending
- 1997-05-30 KR KR1019980709599A patent/KR20000016036A/ko not_active Application Discontinuation
- 1997-05-30 AT AT97925031T patent/ATE208899T1/de not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6118693B2 (ja) * | 1977-10-31 | 1986-05-14 | Hitachi Ltd | |
JPS604929B2 (ja) * | 1977-11-11 | 1985-02-07 | 株式会社日立製作所 | 比色分析方法 |
JPS6350743A (ja) * | 1986-08-20 | 1988-03-03 | Hitachi Ltd | 溶血のある血液試料の分析方法 |
JPH05505243A (ja) * | 1990-10-11 | 1993-08-05 | シナームド、インコーポレーテッド | 血清鉄アッセイに関する試薬及び方法 |
JPH08101191A (ja) * | 1994-08-03 | 1996-04-16 | Boehringer Mannheim Gmbh | 溶血による干渉を回避する検体の分析方法 |
Non-Patent Citations (2)
Title |
---|
B. HAHN, D. L. VLASTELICA, L. R. SNYDER, J. FURDA, AND K. J. M. RAO: ""Polychromatic Analysis: New Applications of an Old Technique"", CLINICAL CHEMISTRY, vol. 第25巻、第6号, JPN4006008030, 15 July 1979 (1979-07-15), US, pages 951 - 959, ISSN: 0000734733 * |
O. SONNTAG: ""Haemolysis as an Interference Factor in Clinical Chemistry"", JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, vol. 第24巻、第2号, JPN4006008029, 1986, pages 127 - 139, XP002042642, ISSN: 0000734732 * |
Also Published As
Publication number | Publication date |
---|---|
IL126718A0 (en) | 1999-08-17 |
EP0906569B1 (de) | 2001-11-14 |
CA2255843C (en) | 2004-07-20 |
CZ391098A3 (cs) | 1999-11-17 |
PL330229A1 (en) | 1999-05-10 |
AU3031497A (en) | 1998-01-05 |
KR20000016036A (ko) | 2000-03-25 |
US6207459B1 (en) | 2001-03-27 |
TW408223B (en) | 2000-10-11 |
CA2255843A1 (en) | 1997-12-04 |
WO1997045732A1 (de) | 1997-12-04 |
EP0906569A1 (de) | 1999-04-07 |
CN1220007A (zh) | 1999-06-16 |
DE59705397D1 (de) | 2001-12-20 |
NZ332444A (en) | 1999-05-28 |
ATE208899T1 (de) | 2001-11-15 |
JP3814300B2 (ja) | 2006-08-23 |
DE19622089A1 (de) | 1997-12-04 |
ES2163775T3 (es) | 2002-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pettigrew et al. | Simplified colorimetric determination of thiocyanate in biological fluids, and its application to investigation of the toxic amblyopias | |
Zwart et al. | A multi-wavelength spectrophotometric method for the simultaneous determination of five haemoglobin derivatives | |
US6268167B1 (en) | Methods for determining an analyte in a plasma or serum sample which may be contaminated with interfering substances resulting from hemolysis | |
EP0618449B1 (en) | Method for the determination of hemoglobin adducts | |
JP3814300B2 (ja) | ヘモグロビンを含有する医療サンプルの分析方法 | |
EP2319937A1 (en) | Blood component measurement method utilizing hemolyzed whole blood, and kit for the method | |
Dennis et al. | Measuring percent oxygen saturation of hemoglobin, percent carboxyhemoglobin and methemoglobin, and concentrations of total hemoglobin and oxygen in blood of man, dog, and baboon. | |
CN104198472B (zh) | 一种稳定的糖化白蛋白检测试剂盒 | |
EP0215170B1 (en) | Single color reading method for determining fructosamine | |
JP2004535568A (ja) | 全血、血漿、および血清における外因性血液代用物による干渉によって影響を受けた血液分析パラメータ結果の自動補正法 | |
Stewart | Evaluation of a reagent-strip method for glucose in whole blood, as compared with a hexokinase method. | |
JP4144117B2 (ja) | グルコースの測定方法及び測定装置 | |
JP3598273B2 (ja) | ヘモグロビン妨害を排除しつつアルカリホスファターゼを測定する方法 | |
Ressler et al. | Improved method for determining serum protein concentrations in the far ultraviolet. | |
Brunton et al. | An assessment of a reflectance meter system for measurement of plasma or blood glucose in the clinic or side ward | |
MXPA98009703A (en) | Method for the analysis of medical samples containing hemoglob | |
Hertz et al. | Molar absorption coefficients for bilirubins in adult and infant serum with determination of an isosbestic point | |
KR20000016035A (ko) | 알부민을 측정하는 동안 헤모글로빈 오류를 제거하는 방법 | |
Porter et al. | Hemoglobin interference with Du Pont Automatic Clinical Analyzer procedure for calcium. | |
JPH0772157A (ja) | 糖化蛋白の定量方法およびその定量用キット | |
Sharma et al. | Enzymic clearing of lipaemic serum following total parenteral nutrition: determination of neonatal bilirubin as a model | |
JPH02122267A (ja) | ヘモグロビン定量試薬キット及びそれを用いるヘモグロビン定量方法 | |
JPS58106441A (ja) | 生化学試料中のクロモゲンの測定法 | |
JPH01101447A (ja) | 吸光分析における濁り度測定方法 | |
KR20000010767A (ko) | 의학 샘플 분석시 헤모글로빈 오류를 제거하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040409 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040409 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060516 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060605 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090609 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100609 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110609 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110609 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120609 Year of fee payment: 6 |
|
LAPS | Cancellation because of no payment of annual fees |